PREVENTION OF INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS

Authors
SERODY JS SHEA TC
Citation
Js. Serody et Tc. Shea, PREVENTION OF INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS, Infectious disease clinics of North America, 11(2), 1997, pp. 459
Citations number
72
Categorie Soggetti
Infectious Diseases",Immunology
Journal title
Infectious disease clinics of North America → ACNP
ISSN journal
08915520
Volume
11
Issue
2
Year of publication
1997
Database
ISI
SICI code
0891-5520(1997)11:2<459:POIIBT>2.0.ZU;2-E
Abstract
Done marrow transplantation (BMT) is increasingly used in the treatmen t of hematologic malignancies, solid tumors, and congenital diseases. The number of patients receiving a BMT increased from approximately 50 00 in 1989 to 12,000 in 1995. Infectious complications are the most co mmon cause of morbidity and mortality in the peritransplant period in patients undergoing autologous BMT. Additionally, infectious complicat ions are a serious cause of complications in recipients of matched sib ling allogeneic BMT, unrelated BMT, and related mismatched BMT.